Venkatasubbarao K, Peterson L, Zhao S, Hill P, Cao L, Zhou Q, Nawrocki ST, Freeman JW. Inhibiting signaltransducer and activator of transcription-3 increases response to gemcitabineand delays progression of pancreatic cancer.Mol Cancer. 2013 Sep 11;12(1):104.
Gong J, Xie J, Bedolla R, Rivas P, Chakravarthy D, Freeman JW, Reddick R, Kopetz S, Peterson A, Wang H, Fischer SM, Kumar AP. Combined Targeting ofSTAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer.Cancer Res. 2014 Mar 1;20(5):1259-73.
Zhao S, Cao L, Freeman JW. Knockdown of RON receptorkinase delays but does not prevent tumor progression while enhancing HGF/METsignaling in pancreatic cancer cell lines. Oncogenesis. 2013 Oct 7;2:e76.
Carew JS, Espitia CM, Zhao W, Kelly KR, Coffey M, Freeman JW, Nawrocki ST. Reolysinis a novel reovirus-based agent that induces endoplasmic reticularstress-mediated apoptosis in pancreatic cancer. Cell Death Dis. 2013 Jul 18;4:e728.
Bera A, Zhao S, Cao L, Chiao PJ, Freeman, JW. OncogenicK-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis thatinduces expression of MMP9 and uPA in human pancreas progenitor cells. PLoS One. 2013 Dec 5;8(12):e82282.